Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 211
Filtrar
1.
Plast Reconstr Surg ; 144(2): 189e-196e, 2019 08.
Artigo em Inglês | MEDLINE | ID: mdl-31348336

RESUMO

BACKGROUND: Injectable hyaluronic acid fillers have been widely applied in the clinical treatment of facial wrinkles. However, further information and clinical evidence concerning dermal changes and hyaluronic acid filler longevity after injection and diffusion pattern are limited. METHODS: The authors evaluated the longevity and diffusion pattern of two hyaluronic acid fillers generated by different cross-linking technologies used in the treatment of nasolabial folds using high-frequency ultrasound. Forty-one subjects were treated with Restylane 2 and the remaining 41 were treated with Dermalax DEEP. Wrinkle severity rating scale score and high-frequency ultrasound evaluation of nasolabial folds were performed before and after the injection of hyaluronic acid filler. The ultrasound images were acquired and analyzed to determine dermal thickness and the shape and distribution of hyaluronic acid filler. RESULTS: At 2 and 24 weeks from baseline, increased dermal thickness induced by hyaluronic acid filler treatment was not significantly different between groups. At 48 weeks after injection, increased dermal thicknesses of the Restylane 2 group (0.14 ± 0.12 mm) were much lower than those of the Dermalax DEEP group (0.20 ± 0.13 mm). Ultrasound examination revealed that hyaluronic acid materials form well-demarcated and hypoechogenic areas. Restylane 2 tended to form a more diffuse pattern, with multiple smaller bubbles, whereas Dermalax DEEP developed into a more localized configuration, with larger clumps. CONCLUSIONS: This study is the first long-term assessment of nasolabial fold correction that reveals the performance of different hyaluronic acid materials in vivo and validates high-frequency ultrasound as a simple and rapid modality. Hyaluronic acid fillers generated by different cross-linking technologies display differential diffusion patterns in skin tissues. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.


Assuntos
Preenchedores Dérmicos/administração & dosagem , Ácido Hialurônico/uso terapêutico , Sulco Nasogeniano/fisiopatologia , Terapia por Ultrassom/métodos , Adulto , Idoso , Alantoína/uso terapêutico , Técnicas Cosméticas , Combinação de Medicamentos , Estética , Feminino , Seguimentos , Hexaclorofeno/uso terapêutico , Humanos , Ácido Hialurônico/análogos & derivados , Injeções Intradérmicas , Masculino , Pessoa de Meia-Idade , Medição de Risco , Método Simples-Cego , Envelhecimento da Pele/efeitos dos fármacos , Esqualeno/uso terapêutico , Taiwan , Fatores de Tempo , Resultado do Tratamento
2.
Bioorg Med Chem Lett ; 29(14): 1689-1693, 2019 07 15.
Artigo em Inglês | MEDLINE | ID: mdl-31129054

RESUMO

Glucose-regulated protein 78 (GRP78) is the ER resident 70 kDa heat shock protein 70 (HSP70) and has been hypothesized to be a therapeutic target for various forms of cancer due to its role in mitigating proteotoxic stress in the ER, its elevated expression in some cancers, and the correlation between high levels for GRP78 and a poor prognosis. Herein we report the development and use of a high throughput fluorescence polarization-based peptide binding assay as an initial step toward the discovery and development of GRP78 inhibitors. This assay was used in a pilot screen to discover the anti-infective agent, hexachlorophene, as an inhibitor of GRP78. Through biochemical characterization we show that hexachlorophene is a competitive inhibitor of the GRP78-peptide interaction. Biological investigations showed that this molecule induces the unfolded protein response, induces autophagy, and leads to apoptosis in a colon carcinoma cell model, which is known to be sensitive to GRP78 inhibition.


Assuntos
Proteínas de Choque Térmico HSP70/efeitos dos fármacos , Hexaclorofeno/uso terapêutico , Ensaios de Triagem em Larga Escala/métodos , Chaperona BiP do Retículo Endoplasmático , Hexaclorofeno/farmacologia , Humanos
3.
Acta Derm Venereol ; 96(7): 948-953, 2016 Nov 02.
Artigo em Inglês | MEDLINE | ID: mdl-26939522

RESUMO

The aim of this randomized controlled trial was to assess the efficacy of a cream containing ceramides and magnesium (Cer-Mg) in the treatment of mild to moderate atopic dermatitis and to compare it with hydrocortisone and a commonly used emollient (unguentum leniens; cold cream). A total of 100 patients, randomized into 2 groups, were treated for 6 weeks simultaneously (left vs. right side of the body) with either Cer-Mg and hydrocortisone (group I) or Cer-Mg and emollient (group II). The primary outcome was a reduction in severity of lesions as assessed by (local) SCORAD (SCORing Atopic Dermatitis). Levels of trans-epidermal water loss (TEWL), skin hydration, and natural moisturizing factors (NMF) were then measured. After 6 weeks, group I showed comparable significant improvement in SCORAD and TEWL, while in group II, the decrease in SCORAD and TEWL was significantly greater after Cer-Mg compared with emollient. Finally, Cer-Mg cream was more effective in improving skin hydration and maintenance of levels of NMF than hydrocortisone and emollient.


Assuntos
Alantoína/uso terapêutico , Dermatite Atópica/tratamento farmacológico , Emolientes , Hexaclorofeno/uso terapêutico , Hidrocortisona/uso terapêutico , Pomadas , Esqualeno/uso terapêutico , Adulto , Método Duplo-Cego , Combinação de Medicamentos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento
4.
J Allergy Clin Immunol Pract ; 2(4): 396-9, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25017526

RESUMO

Methicillin-resistant Staphylococcus aureus (MRSA) is a frequent cause of recurrent skin and soft tissue infections. For patients with atopic dermatitis, recurrent skin infections with MRSA often lead to eczema exacerbation. There currently is no standard practice in the prevention of recurrent MRSA soft tissue infections in the general and the atopic dermatitis populations. The current article reviews recent data on S aureus decolonization treatments for the prevention of recurrent MRSA soft tissue infections in the community setting.


Assuntos
Antibacterianos/uso terapêutico , Dermatite Atópica/terapia , Staphylococcus aureus Resistente à Meticilina/fisiologia , Infecções Estafilocócicas/terapia , Animais , Dermatite Atópica/epidemiologia , Hexaclorofeno/uso terapêutico , Humanos , Higiene , Mupirocina/uso terapêutico , Recidiva , Características de Residência , Pele/efeitos dos fármacos , Pele/microbiologia , Infecções Estafilocócicas/epidemiologia
5.
Antimicrob Agents Chemother ; 56(2): 1084-6, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22083485

RESUMO

Recurrent community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin infections are an increasingly common problem. However, there are no data on the efficacy of decolonization regimens. We prospectively evaluated 31 patients with recurrent CA-MRSA skin infections who received nasal mupirocin, topical hexachlorophene body wash, and an oral anti-MRSA antibiotic. The mean number of MRSA infections after the intervention decreased significantly from baseline (0.03 versus 0.84 infections/month, P = <0.0001). This regimen appears promising at preventing recurrent CA-MRSA infections.


Assuntos
Antibacterianos/uso terapêutico , Infecções Comunitárias Adquiridas/prevenção & controle , Hexaclorofeno/uso terapêutico , Staphylococcus aureus Resistente à Meticilina/efeitos dos fármacos , Mupirocina/uso terapêutico , Infecções Cutâneas Estafilocócicas/prevenção & controle , Administração Intranasal , Administração Oral , Administração Tópica , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Antibacterianos/administração & dosagem , Antibacterianos/farmacologia , Anti-Infecciosos Locais , Infecções Comunitárias Adquiridas/tratamento farmacológico , Infecções Comunitárias Adquiridas/microbiologia , Feminino , Hexaclorofeno/administração & dosagem , Hexaclorofeno/farmacologia , Humanos , Masculino , Pessoa de Meia-Idade , Mupirocina/administração & dosagem , Mupirocina/farmacologia , Recidiva , Infecções Cutâneas Estafilocócicas/tratamento farmacológico , Infecções Cutâneas Estafilocócicas/microbiologia , Resultado do Tratamento , Adulto Jovem
7.
Emerg Infect Dis ; 11(4): 526-32, 2005 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15829189

RESUMO

An outbreak of community-associated methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infection (SSTI) occurred in a college football team from August to September 2003. Eleven case-players were identified, and boils were the most common sign. Linemen had the highest attack rate (18%). Among 99 (93% of team) players with cultured specimens, 8 (8%) had positive MRSA nasal cultures. All available case-players' MRSA isolates characterized had the community-associated pulsed-field type USA300. A case-control study found that sharing bars of soap and having preexisting cuts or abrasions were associated with infection. A carrier-control study found that having a locker near a teammate with an SSTI, sharing towels, and living on campus were associated with nasal carriage. Successful outbreak control measures included daily hexachlorophene showers and hygiene education.


Assuntos
Resistência a Meticilina , Infecções Cutâneas Estafilocócicas/epidemiologia , Staphylococcus aureus/efeitos dos fármacos , Adolescente , Adulto , Anti-Infecciosos Locais/uso terapêutico , Portador Sadio , Estudos de Casos e Controles , Futebol Americano , Hexaclorofeno/uso terapêutico , Humanos , Masculino , Mucosa Nasal/microbiologia , Recidiva , Infecções Cutâneas Estafilocócicas/prevenção & controle
8.
Am J Infect Control ; 30(8): S1-46, 2002 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-12461507

RESUMO

The Guideline for Hand Hygiene in Health-Care Settings provides health-care workers (HCWs) with a review of data regarding handwashing and hand antisepsis in health-care settings. In addition, it provides specific recommendations to promote improved hand-hygiene practices and reduce transmission of pathogenic microorganisms to patients and personnel in health-care settings. This report reviews studies published since the 1985 CDC guideline (Garner JS, Favero MS. CDC guideline for handwashing and hospital environmental control, 1985. Infect Control 1986;7:231-43) and the 1995 APIC guideline (Larson EL, APIC Guidelines Committee. APIC guideline for handwashing and hand antisepsis in health care settings. Am J Infect Control 1995;23:251-69) were issued and provides an in-depth review of hand-hygiene practices of HCWs, levels of adherence of personnel to recommended handwashing practices, and factors adversely affecting adherence. New studies of the in vivo efficacy of alcohol-based hand rubs and the low incidence of dermatitis associated with their use are reviewed. Recent studies demonstrating the value of multidisciplinary hand-hygiene promotion programs and the potential role of alcohol-based hand rubs in improving hand-hygiene practices are summarized. Recommendations concerning related issues (e.g., the use of surgical hand antiseptics, hand lotions or creams, and wearing of artificial fingernails) are also included.


Assuntos
Anti-Infecciosos Locais/uso terapêutico , Desinfecção das Mãos/normas , Controle de Infecções/normas , Álcoois/uso terapêutico , Clorexidina/uso terapêutico , Hexaclorofeno/uso terapêutico , Humanos , Higiene , Infecções/transmissão , Compostos de Amônio Quaternário/uso terapêutico , Pele/microbiologia , Fenômenos Fisiológicos da Pele , Sabões , Triclosan , Xilenos
9.
J Clin Periodontol ; 22(6): 423-6, 1995 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-7560219

RESUMO

Previous studies indicate that triclosan reduces the pain and other symptoms after chemically-induced inflammation in the oral mucosa and skin when sodium lauryl sulfate (SLS) is used as an irritant. The aim of the present study was to examine whether triclosan has an effect on the inflammation in human skin caused by intradermal administration of histamine. 9 female volunteers participated in a double-blind study, and skin patch tests were performed in 2 series. In the 1st, the skin was pre-treated for 1 h with triclosan before the histamine was applied. In the 2nd, the histamine reaction was elicited first and triclosan applied subsequently. The effect of triclosan on the weals formed in the skin after histamine application was measured. It was found that triclosan reduced the size of the weals markedly when triclosan was applied after the weals were formed, and that pre-treatment of the skin had only a slight effect. It is assumed that triclosan has an effect on the cascade reactions of inflammation elicited by histamine. 2 other phenols tested in the same study had similar effects.


Assuntos
Anti-Infecciosos Locais/uso terapêutico , Anti-Inflamatórios não Esteroides/uso terapêutico , Dermatite/prevenção & controle , Histamina/efeitos adversos , Triclosan/uso terapêutico , Administração Cutânea , Adulto , Anti-Infecciosos Locais/administração & dosagem , Anti-Inflamatórios não Esteroides/administração & dosagem , Clorofenóis/administração & dosagem , Clorofenóis/uso terapêutico , Método Duplo-Cego , Feminino , Hexaclorofeno/administração & dosagem , Hexaclorofeno/uso terapêutico , Histamina/administração & dosagem , Humanos , Injeções Intradérmicas , Pessoa de Meia-Idade , Testes do Emplastro , Placebos , Triclosan/administração & dosagem
10.
Lik Sprava ; (3-4): 132-5, 1995.
Artigo em Ucraniano | MEDLINE | ID: mdl-8819944

RESUMO

A new low-toxic antimicrobial preparation is proposed to impregnate woven materials used in treatment of pyo-inflammatory wounds contaminated with Gram-positive and Gram-negative bacteria as well as with pathogenic fungi as a result of an artificial infection. Sodic form of sudamate is less toxic, its bactericidal effect being 3-5 times more effective than that of hexachlorophene.


Assuntos
Anti-Infecciosos Locais/uso terapêutico , Sódio/uso terapêutico , Animais , Anti-Infecciosos Locais/toxicidade , Bandagens , Candidíase/tratamento farmacológico , Células Cultivadas , Avaliação Pré-Clínica de Medicamentos , Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Infecções por Bactérias Gram-Positivas/tratamento farmacológico , Cobaias , Hexaclorofeno/uso terapêutico , Hexaclorofeno/toxicidade , Humanos , Masculino , Compostos Orgânicos , Ratos , Sódio/toxicidade , Infecção dos Ferimentos/tratamento farmacológico
11.
Arch Dis Child ; 68(5 Spec No): 594-6, 1993 May.
Artigo em Inglês | MEDLINE | ID: mdl-8323363

RESUMO

The use of antiseptic treatment during cord care varies from unit to unit. Although it may reduce bacterial colonisation it may also delay cord separation. Where antiseptic treatment is used there is uncertainty as to the best agent. Hexachlorophane powder (0.3%) and 4% chlorhexidene detergent were each compared with dry cord care as a control on a two ward maternity unit in a six month open study. Of 133 infants treated with hexachlorophane 44 (33%) became heavily colonised with Staphylococcus aureus compared with 80 (47%) of 171 controls; a reduction of one third. Chlorhexidene reduced colonisation by more than half; 17 (16%) of 104 compared with 41 (42%) of 98 controls. Chlorhexidene was associated with cord attachment at 10 days in 29 (28%) infants compared with 31 of 515 (6%) infants when it was not used. Hexachlorophane was more acceptable to the nursing staff. The reduction in colonisation with the two compounds was largely due to the suppression of cross infection.


Assuntos
Clorexidina/uso terapêutico , Infecção Hospitalar/prevenção & controle , Hexaclorofeno/uso terapêutico , Berçários Hospitalares , Cordão Umbilical/microbiologia , Contagem de Colônia Microbiana , Humanos , Recém-Nascido , Infecções Estafilocócicas/prevenção & controle , Staphylococcus aureus/isolamento & purificação , Fatores de Tempo
12.
Klin Khir (1962) ; (1): 16-7, 1993.
Artigo em Russo | MEDLINE | ID: mdl-10912018

RESUMO

The experience with the use of P-47 catalase preparation for treatment of 155 patients with sluggish wounds and ulcers is summarized. Use of P-47 preparation contributes to increase in catalase activity and hence to normalization of the course of regenerative processes. P-47 preparation is recommended as an effective means for treatment of sluggish wounds and ulcers.


Assuntos
Catalase/uso terapêutico , Úlcera/tratamento farmacológico , Cicatrização/efeitos dos fármacos , Idoso , Doença Crônica , Combinação de Medicamentos , Hexaclorofeno/uso terapêutico , Humanos , Lactose/uso terapêutico , Pessoa de Meia-Idade , Ácidos Esteáricos/uso terapêutico , Fatores de Tempo
13.
Artigo em Chinês | MEDLINE | ID: mdl-1776440

RESUMO

Outbreaks of skin infections due to Staphylococcus aureus continue to be a major problem in newborn nurseries. In this report, we described how the staphylococcal skin infections were controlled in the nursery during the last 5 1/2 years. An outbreak of staphylococcal skin infection (totally 29 cases) developed in January 1985, and declined dramatically to 3 cases in March of the same year when 3% hexachlorophene (HCP) bathing was used (period 1-January 1985 to March 1985). The infections increased to 30 cases in May when HCP bathing was discontinued and was replaced by baby soap baths (period 2-April 1985 to May 1985). Once again, HCP bathing (period 3-June 1985 to January 1987) was reinstituted and infection rate was reduced. After discontinuation of HCP (period 4-February 1987 to March 1987), another outbreak of staphylococcal skin infection reappeared. It was controlled again with HCP bathing (period 5-April 1987 to April 1988). Daily baby soap baths were continued during period 6 (May 1988 to October 1988), and skin infections increased again. Finally in period 7 (November 1988 to June 1990), daily baby soaps were reinstituted and a triple dye was applied daily to the cord and to the surrounding skin (1 inch diameter) until discharge. During this period, staphylococcal skin infections was reduced to 1-4 cases and no more outbreaks occurred. Our data confirmed that 3% HCP bathing of newborns reduced the infection rate of Staphylococcus aureus during an endemic period, and supported that triple dye may be an alternative to HCP for preventing staphylococcal skin infection in a newborn nursery.


Assuntos
Infecção Hospitalar/prevenção & controle , Dermatopatias Infecciosas/prevenção & controle , Infecções Estafilocócicas/prevenção & controle , Anti-Infecciosos/uso terapêutico , Banhos , Infecção Hospitalar/epidemiologia , Surtos de Doenças , Combinação de Medicamentos , Violeta Genciana/uso terapêutico , Hexaclorofeno/uso terapêutico , Humanos , Recém-Nascido , Berçários Hospitalares , Proflavina/uso terapêutico , Compostos de Amônio Quaternário/uso terapêutico , Dermatopatias Infecciosas/epidemiologia , Infecções Estafilocócicas/epidemiologia
14.
Aust Vet J ; 64(11): 328-32, 1987 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-3447575

RESUMO

Controlled tests were used to assess the efficacy of anthelmintics against immature paramphistomes, predominantly Calicophoron calicophorum, in 127 calves which were exposed to contaminated pasture for 7 weeks, treated and slaughtered. When a combination product of oxyclozanide and levamisole was used, oxyclozanide at 18.7 mg/kg reduced parasite numbers in the small intestine, abomasum and rumen-reticulum by 61 to 96.1%, 50.0 to 92.6% and 56.5 to 98.1%, respectively. When 2 doses were given 3 days apart, oxyclozanide was 99.9%, 100% and 100% effective, respectively, in the above organs, and produced improvement in clinically affected calves. This treatment elicited transient diarrhoea. Hexachlorophene at 20 mg/kg as a single dose was 99.5%, 100% and 100% effective against the fluke in the small intestine, abomasum and rumen respectively but severe neurological signs were seen in some calves. Niclosamide at 160 mg/kg given as single or 2 doses 3 days apart was 91.1% and 92.6% effective, respectively, against the parasites in the small intestine. No toxicity was noted. Closantel, at 7.5 mg/kg was not effective. Oxyclozanide and niclosamide when given as a single treatment had varying activity. Two doses of oxyclozanide and a single dose of hexachlorophene gave consistent results. Further tests based on reduction of faecal egg counts, 10 to 14 days after treatment were conducted with oxyclozanide and hexachlorophene against mature paramphistomes in 207 cattle. Oxyclozanide as a single dose or 2 doses 3 days apart at 12.8 to 18.7 mg/kg was 93.6 to 97.5% effective in reducing egg counts. Hexachlorophene at 20 mg/kg was 83.0% effective.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Anti-Helmínticos/uso terapêutico , Doenças dos Bovinos/tratamento farmacológico , Infecções por Trematódeos/veterinária , Animais , Bovinos , Fezes/parasitologia , Feminino , Hexaclorofeno/uso terapêutico , Ionóforos/uso terapêutico , Levamisol/uso terapêutico , Niclosamida/uso terapêutico , Oxiclozanida/uso terapêutico , Paramphistomatidae , Contagem de Ovos de Parasitas/veterinária , Salicilanilidas/uso terapêutico , Infecções por Trematódeos/tratamento farmacológico
19.
J Am Acad Dermatol ; 9(5): 759-65, 1983 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-6643773

RESUMO

The skin cannot be sterilized because approximately 20% of the resident flora are beyond the reach of surgical scrubs and antiseptics. The goal of surgical preparation of the skin with antiseptics is to remove transient and pathogenic microorganisms on the skin surface and to reduce the resident flora to a low level. Four antiseptics which have been popular over the past two decades are discussed. Benzalkonium chloride is somewhat unstable on the skin and is too prone to contamination to be in general use. Hexachlorophene is not recommended due to narrow spectrum and risks secondary to percutaneous absorption. The iodophors are excellent antiseptics, but recent studies raise questions about effectiveness and contamination. Chlorhexidine is a very safe and effective antiseptic. Comparison studies with chlorhexidine, hexachlorophene, and iodophors show chlorhexidine to be the most effective agent. Chlorhexidine can be toxic to the middle ear and irritating to the eyes with direct contact. Caution should be used in these areas with chlorhexidine and other antiseptics.


Assuntos
Anti-Infecciosos Locais/uso terapêutico , Cuidados Pré-Operatórios , Compostos de Benzalcônio/uso terapêutico , Clorexidina/uso terapêutico , Avaliação de Medicamentos , Etanol/uso terapêutico , Desinfecção das Mãos/métodos , Hexaclorofeno/uso terapêutico , Humanos , Iodóforos/uso terapêutico , Pele/microbiologia , Dermatopatias Infecciosas/prevenção & controle , Infecção da Ferida Cirúrgica/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA